DESIGN A DRUG Trademark

Trademark Overview

On Tuesday, February 29, 2000, a trademark application was filed for DESIGN A DRUG with the United States Patent and Trademark Office. The USPTO has given the DESIGN A DRUG trademark a serial number of 75931685. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 17, 2002. This trademark is owned by Genome Therapeutics Corporation. The DESIGN A DRUG trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, SNP detection and haplotyping, and providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions
design a drug

General Information

Serial Number75931685
Word MarkDESIGN A DRUG
Filing DateTuesday, February 29, 2000
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 17, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, SNP detection and haplotyping, and providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenome Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453

Trademark Events

Event DateEvent Description
Thursday, January 17, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 3, 2001FINAL REFUSAL MAILED
Wednesday, January 31, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2000NON-FINAL ACTION MAILED
Tuesday, July 25, 2000ASSIGNED TO EXAMINER

Related Keywords

drug design genomic development research generating genomes information protein polypeptide pharmocogenomics pertaining